Since 2018, numerous FAP inhibitors (FAPIs) have been developed as tracers for tumor imaging via PET/computed tomography (CT), labelled with short half-life isotopes such as gallium-68 [1,2,3,4,5] or fluorine-18 [6,7]. The gene discussed is FAP; the disease is neoplasm.